FRAG - Overview: Osmotic Fragility, Erythrocytes

Evaluating suspected hereditary spherocytosis-associated hemolytic anemia Confirming or detecting mild spherocytosis

OXYSX - Overview: Oxycodone Screen, Chain of Custody, Random, Urine

Detection of oxycodone and oxymorphone in urine following chain-of-custody procedures This chain-of-custody test is intended to be used in a setting where the test results can be used definitively to make a diagnosis. Chain of custody is...

NMRLP - Overview: Nuclear Magnetic Resonance Lipoprotein Profile, Serum

Assessment and management of a patient's risk for atherosclerotic cardiovascular disease Identifying residual risk that may be present in some patients on cholesterol targeting treatment

PCTTS - Overview: Purkinje Cell Cytoplasmic Antibody Type Tr (PCA-Tr) Titer, Serum

Serological testing for Purkinje cell cytoplasmic antibody-Tr for patients with acquired cerebellar ataxia of undetermined etiology, particularly if the patient has a history of Hodgkin lymphoma Reporting an end titer result from serum...

RIVAR - Overview: Rivaroxaban, Anti-Xa, Plasma

Measuring rivaroxaban concentration in selected clinical situations (eg, kidney insufficiency, assessment of compliance, periprocedural measurement of drug concentration, suspected overdose, advanced age, and extremes of body weight)

PU1 - Overview: PU.1 Immunostain, Technical Component Only

Classification of lymphomas

PCPMX - Overview: Phencyclidine (PCP) Confirmation, Chain of Custody, Meconium

Detection of in utero drug exposure up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen...

SABP - Overview: Streptococcal Antibodies Profile, Serum

Demonstration of acute or recent streptococcal infection using both antistreptolysin O and anti-DNase B titers

ETGSR - Overview: Ethyl Glucuronide Screen with Reflex, Random, Urine

Screening for drug abuse involving alcohol

CARF - Overview: Carbamazepine, Free, Serum

Monitoring unbound or free carbamazepine levels in patients where the total carbamazepine result is within the therapeutic range, but the patient is experiencing side effects Monitoring carbamazepine (free) therapy in patients who are...

HSCRP - Overview: C-Reactive Protein, High Sensitivity, Serum

Assessment of risk of developing myocardial infarction in patients presenting with acute coronary syndromes Assessment of risk of developing cardiovascular disease or ischemic events in individuals who do not manifest disease at present

LALB - Overview: Lysosomal Acid Lipase, Blood

Evaluation of patients with a clinical presentation suggestive of lysosomal acid lipase deficiency using blood specimens This test is not useful to determine carrier status for cholesteryl ester storage disease or Wolman disease.

PBUCR - Overview: Lead/Creatinine Ratio, Random, Urine

Detecting clinically significant lead exposure, a toxic heavy metal, using random urine specimens

BFLA1 - Overview: Lipid Analysis, Body Fluid

Distinguishing between chylous and nonchylous effusions

SMAS - Overview: Smooth Muscle Antibody Screen, Serum

Evaluation of patients with hepatitis of unknown origin associated with hypergammaglobulinemia and/or abnormal liver enzymes

SCERA - Overview: Saccharomyces cerevisiae Antibody, IgA, Serum

Measuring IgA anti-Saccharomyces cerevisiae antibodies as a part of a profile to aid in distinguishing between ulcerative colitis and Crohn disease in patients for whom the specific diagnosis is unclear based on endoscopic, pathologic, and...

VMAR - Overview: Vanillylmandelic Acid, Random, Urine

Screening children for catecholamine-secreting tumors using a random urine collection when requesting vanillylmandelic acid only Supporting a diagnosis of neuroblastoma Monitoring patients with a treated neuroblastoma

WEEPC - Overview: Western Equine Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid

Aiding in the diagnosis of Western equine encephalitis using spinal fluid specimens

CCMVU - Overview: Congenital Cytomegalovirus (cCMV), Molecular Detection, PCR, Urine

Aiding in the rapid diagnosis of cytomegalovirus infections in neonates 21 days of age or younger using urine specimens

6MAMM - Overview: 6-Monoacetylmorphine (6-MAM), Confirmation, Meconium

Detection of in utero heroin exposure up to 5 months before birth

MAGRU - Overview: Magnesium/Creatinine Ratio, Random, Urine

Assessing the cause of abnormal serum magnesium concentrations Determining whether nutritional magnesium loads are adequate Calculating urinary calcium oxalate and calcium phosphate supersaturation and assessing kidney stone risk.

LGBBS - Overview: Globotriaosylsphingosine, Blood Spot

Screening of patients with Fabry disease using dried blood spots when a serum specimen is not available This test should not be used for newborn screening followup.

CRU - Overview: Chromium, 24 Hour, Urine

Screening for occupational exposure to chromium Monitoring metallic prosthetic implant wear

AMS - Overview: Amylase, Total, Serum

Diagnosis and management of pancreatitis Evaluation of pancreatic function

BIOTN - Overview: Biotin, Serum

Measurement of biotin in serum Assessment of biotin concentrations in individuals taking biotin supplements Investigation of unexpected results from immunoassays that utilize biotin-streptavidin detection methods This test is not useful...

CLD18 - Overview: Claudin 18 (CLDN18) (43-14A), Semi-Quantitative Immunohistochemistry, Manual

Identification of tumor cells expressing claudin 18 As an aid in screening patients who may be eligible for VYLOY (zolbetuximab) treatment

CEA - Overview: Carcinoembryonic Antigen (CEA), Serum

Monitoring colorectal cancer and selected other cancers such as medullary thyroid carcinoma May be useful in assessing the effectiveness of chemotherapy or radiation treatment This test is not useful for screening the general population...

HAPT - Overview: Haptoglobin, Serum

Confirmation of intravascular hemolysis

EXHD - Overview: Hematologic Disorders, DNA Extract and Hold, Varies

Reserving DNA on any specimen for which molecular analysis requiring DNA may be necessary at a future date, ensuring that adequate material for testing is available

OMHC - Overview: Oxcarbazepine Metabolite, Serum

Monitoring serum concentration during oxcarbazepine therapy Assessing compliance Assessing potential toxicity

CSPMM - Overview: Plasma Cell Myeloma Pre-Analysis Cell Sorting, Bone Marrow

Pre-analysis cell sorting for the MayoComplete Plasma Cell Myeloma panel

EURO - Overview: Phospholipase A2 Receptor, Enzyme Linked Immunosorbent Assay, Serum

Distinguishing primary from secondary membranous nephropathy

PNYF - Overview: Phenytoin, Free, Serum

Monitoring for appropriate therapeutic concentration of free phenytoin: free phenytoin level is the best indicator of adequate therapy in renal failure Assessing compliance and toxicity

RKUR - Overview: Potassium, Random, Urine

Determining the cause for hyper- or hypokalemia using a random urine specimen

NEFA - Overview: Free Fatty Acids, Total, Serum

Evaluation of metabolic status of patients with endocrinopathies Monitoring of control of diabetes mellitus Monitoring the effects of therapeutic diet/exercise lifestyle changes

TRIGC - Overview: Triglycerides, CDC, Serum

Measurement of triglycerides as part of lipoprotein profiling

SDLDL - Overview: Small Dense Low Density Lipoprotein Cholesterol, Serum

Aiding in risk management of lipoprotein disorders associated with cardiovascular disease when used in conjunction with other lipid measurements and clinical evaluation

NAS - Overview: Sodium, Serum

Assessing acid-base balance, water balance, water intoxication, and dehydration

THEO - Overview: Theophylline, Serum

Assessing and adjusting theophylline dosage for optimal therapeutic level Assessing theophylline toxicity

VALPF - Overview: Valproic Acid, Free, Serum

Monitoring free valproic acid in therapy Assessing compliance Evaluating potential toxicity

VIP - Overview: Vasoactive Intestinal Polypeptide, Plasma

Detecting vasoactive intestinal polypeptide-producing tumors in patients with chronic diarrheal diseases

PENTS - Overview: Pentobarbital, Serum

Monitoring of pentobarbital therapy treatment

CRUO - Overview: Chromium Occupational Exposure, Random, Urine

Screening for occupational exposure to chromium

FBUMT - Overview: Bupropion and Metabolite, Serum

Bupropion and Metabolite, Serum

FETCE - Overview: Mitochondrial Respiratory Chain Enzyme Analysis (ETC) - Skin Fibroblasts

Mitochondrial Respiratory Chain Enzyme Analysis (ETC) - Skin Fibroblasts

FDM - Overview: Dextromethorphan (DM), Serum

Dextromethorphan (DM), Serum

GNBLC - Overview: Bleeding Disorders, Comprehensive Gene Panel, Next-Generation Sequencing, Varies

Evaluating hereditary bleeding in patients with a personal or family history suggestive of a hereditary bleeding disorder Confirming a hereditary bleeding disorder diagnosis with the identification of a known or suspected disease-causing...

GNPLT - Overview: Platelet Disorders, Comprehensive Gene Panel, Next-Generation Sequencing, Varies

Evaluating hereditary platelet disorders in patients with a personal or family history suggestive of a hereditary platelet disorder Diagnosing hereditary platelet disorders for patients in whom phenotypic testing is nondiagnostic, but...

CTP10 - Overview: Catecholamine Fractionation, Standing, Plasma, Free

Diagnosis of pheochromocytoma and paraganglioma in specimens collected from individuals in a standing position, as an auxiliary test to fractionated plasma and urine metanephrine measurements Diagnosis and follow-up of patients with...

MSMRD - Overview: Myeloma Stratification and Risk-Adapted Therapy with Reflex to Minimal Residual Disease, Bone Marrow

Risk stratification of patients with treated multiple myeloma, which can assist in determining treatment and management decisions Risk stratification of patients with newly diagnosed multiple myeloma